Aubagio ‘slows brain atrophy in RRMS patients’
Aubagio ‘slows brain atrophy in RRMS patients’
Genzyme has announced results from magnetic resonance imaging (MRI) analysis of participants in the Phase III TEMSO clinical trial showing Aubagio was able to slow the loss of brain volume (or atrophy) versus a placebo over two years in patients with relapsing-remitting multiple sclerosis (RRMS)... Read More - http://www.ms-uk.org/MSnews
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 0 Replies
- 11294 Views
-
Last post by accordingnature495
-
- 0 Replies
- 1715 Views
-
Last post by NHE
-
- 0 Replies
- 1365 Views
-
Last post by NHE
-
- 4 Replies
- 1496 Views
-
Last post by NHE
-
- 0 Replies
- 1203 Views
-
Last post by NHE
-
- 0 Replies
- 1499 Views
-
Last post by NHE
-
- 0 Replies
- 1944 Views
-
Last post by frodo
-
- 0 Replies
- 2010 Views
-
Last post by NHE
-
- 0 Replies
- 1591 Views
-
Last post by NHE